Trial
NCT03599622
An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Bristol-Myers Squibb
Collaborators
—
Condition
Granulomatous Colitis
Intervention
BMS-986165
Why stopped
Trial terminated because of lack of efficacy in the short term acute phase
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-07-03